Delivery Order SPE2DB20D9354-SPE2DB25FX7L5
Award Date
2/5/25
Potential Completion Date
2/6/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,526.83, is to provide the pharmaceutical product Trikafta, a specialty medication used to treat cystic fibrosis. The order has an ultimate completion date of November 20, 2024. DMS Pharmaceutical Group is a key supplier in the DLA's pharmaceutical supply chain,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $55,580.49 firm fixed-price delivery order under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA. The delivery order is for the pharmaceutical product Trikafta, a specialized medication used to treat cystic fibrosis. The contract has an...
This is a firm fixed-price delivery order award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $88,307.10, is for the delivery of the pharmaceutical product Trikafta, used to treat cystic fibrosis. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $18,526.83, is for the provision of Trikafta, a cystic fibrosis medication, with a period of performance through May 23, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $88,072.35 contract is for the provision of the drug Trikafta, a specialized medication used to treat cystic fibrosis. The order falls under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to supply a comprehensive range of pharmaceutical products, including branded and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, valued at $18,526.83, is for the supply of Trikafta, a specialty medication, to support the medical needs of military healthcare facilities. The contract has an ultimate completion date of December 13, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $36,637.50 contract is for the delivery of the specialized pharmaceutical product Trikafta, a medication used to treat cystic fibrosis. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,633.14 contract is for the delivery of Trikafta 100-50-75 mg/75 mg pharmaceutical product, with a completion date of January 21, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,526.83, is for the provision of the pharmaceutical drug Trikafta in a 100-50-75 mg/150 mg dosage form. The delivery order has an ultimate completion date of November 29, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $73,275.04 contract is for the delivery of Trikafta, a specialty pharmaceutical product, with an ultimate completion date of October 19, 2023. DMS Pharmaceutical Group Inc. holds a large indefinite delivery contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the...